Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Periprocedural myocardial injury and infarction after myocardial revascularization: incidence, clinical features and prognosis].
Armillotta M, Angeli F, Rinaldi A, Bertolini D, Amicone S, Bodega F, Fedele D, Impellizzeri A, Di Iuorio O, Bergamaschi L, Paolisso P, Foà A, Stefanizzi A, Sansonetti A, Canton L, Suma N, Tattilo FP, Cavallo D, Ryabenko K, Casuso Alvarez M, Tortorici G, Pizzi C. Armillotta M, et al. Among authors: sansonetti a. G Ital Cardiol (Rome). 2023 Nov;24(11):880-892. doi: 10.1714/4129.41231. G Ital Cardiol (Rome). 2023. PMID: 37901979 Review. Italian.
Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA.
Paolisso P, Foà A, Bergamaschi L, Angeli F, Fabrizio M, Donati F, Toniolo S, Chiti C, Rinaldi A, Stefanizzi A, Armillotta M, Sansonetti A, Magnani I, Iannopollo G, Rucci P, Casella G, Galiè N, Pizzi C. Paolisso P, et al. Among authors: sansonetti a. Cardiovasc Diabetol. 2021 Sep 24;20(1):192. doi: 10.1186/s12933-021-01384-6. Cardiovasc Diabetol. 2021. PMID: 34560876 Free PMC article.
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.
Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Paolisso P, et al. Among authors: sansonetti a. Cardiovasc Diabetol. 2022 May 15;21(1):77. doi: 10.1186/s12933-022-01506-8. Cardiovasc Diabetol. 2022. PMID: 35570280 Free PMC article.
[Cardiac masses: classification, clinical features and diagnostic approach].
Angeli F, Fabrizio M, Paolisso P, Magnani I, Bergamaschi L, Bartoli L, Stefanizzi A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Tattilo FP, Suma N, Bodega F, Canton L, Rinaldi A, Foà A, Pizzi C. Angeli F, et al. Among authors: sansonetti a. G Ital Cardiol (Rome). 2022 Aug;23(8):620-630. doi: 10.1714/3856.38393. G Ital Cardiol (Rome). 2022. PMID: 36169142 Review. Italian.
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study.
Cesaro A, Gragnano F, Paolisso P, Bergamaschi L, Gallinoro E, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Oreglia JA, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Pizzi C, Barbato E, Calabrò P, Marfella R. Cesaro A, et al. Among authors: sansonetti a. Front Cardiovasc Med. 2022 Sep 27;9:1012220. doi: 10.3389/fcvm.2022.1012220. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36237914 Free PMC article.
Development and Validation of a Diagnostic Echocardiographic Mass Score in the Approach to Cardiac Masses.
Paolisso P, Foà A, Magnani I, Bergamaschi L, Graziosi M, Angeli F, Chiti C, Fabrizio M, Rinaldi A, Stefanizzi A, Armillotta M, Sansonetti A, Gallinoro E, Maietti E, Rucci P, Biagini E, Mattioli AV, Galiè N, Pizzi C. Paolisso P, et al. Among authors: sansonetti a. JACC Cardiovasc Imaging. 2022 Nov;15(11):2010-2012. doi: 10.1016/j.jcmg.2022.06.005. Epub 2022 Aug 17. JACC Cardiovasc Imaging. 2022. PMID: 36357143 Free article. No abstract available.
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Pizzi C, Barbato E. Paolisso P, et al. Among authors: sansonetti a. Pharmacol Res. 2023 Jan;187:106597. doi: 10.1016/j.phrs.2022.106597. Epub 2022 Dec 5. Pharmacol Res. 2023. PMID: 36470546 Free PMC article.
Echocardiographic Markers in the Diagnosis of Cardiac Masses.
Paolisso P, Foà A, Bergamaschi L, Graziosi M, Rinaldi A, Magnani I, Angeli F, Stefanizzi A, Armillotta M, Sansonetti A, Fabrizio M, Amicone S, Impellizzeri A, Tattilo FP, Suma N, Bodega F, Canton L, Gherbesi E, Tuttolomondo D, Caldarera I, Maietti E, Carugo S, Gaibazzi N, Rucci P, Biagini E, Galiè N, Pizzi C. Paolisso P, et al. Among authors: sansonetti a. J Am Soc Echocardiogr. 2023 May;36(5):464-473.e2. doi: 10.1016/j.echo.2022.12.022. Epub 2023 Jan 5. J Am Soc Echocardiogr. 2023. PMID: 36610495
Reply to SGLT-2 inhibitors: Post-infarction interventional effects.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Barbato E, Pizzi C. Paolisso P, et al. Among authors: sansonetti a. Pharmacol Res. 2023 Mar;189:106664. doi: 10.1016/j.phrs.2023.106664. Epub 2023 Jan 13. Pharmacol Res. 2023. PMID: 36642618 Free PMC article. No abstract available.
78 results